Lexicon Pharmaceuticals, Inc.
LXRX
$1.40
$0.064.48%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 115.95M | 139.01M | 194.84M | 237.96M | 258.37M |
| Total Receivables | 2.33M | 2.18M | 47.45M | 3.47M | 2.90M |
| Inventory | 158.00K | 168.00K | 201.00K | 231.00K | 636.00K |
| Prepaid Expenses | 4.09M | 3.73M | 3.32M | 4.53M | 6.71M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 122.53M | 145.08M | 245.81M | 246.19M | 268.61M |
|
|
|||||
| Total Current Assets | 122.53M | 145.08M | 245.81M | 246.19M | 268.61M |
| Net Property, Plant & Equipment | 9.49M | 6.59M | 6.95M | 7.32M | 7.15M |
| Long-term Investments | 44.54M | 44.54M | 44.54M | 44.54M | 44.54M |
| Goodwill | 44.54M | 44.54M | 44.54M | 44.54M | 44.54M |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 29.37M | 29.37M | 368.00K | 368.00K | 828.00K |
| Total Assets | 205.93M | 225.58M | 297.67M | 298.42M | 321.12M |
|
|
|||||
| Total Accounts Payable | 3.80M | 5.90M | 10.69M | 14.80M | 14.20M |
| Total Accrued Expenses | 11.98M | 10.57M | 11.90M | 29.27M | 20.54M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.64M | 909.00K | 43.10M | 1.18M | 1.30M |
| Total Finance Division Other Current Liabilities | 4.30M | 17.46M | 45.00M | -- | -- |
| Total Other Current Liabilities | 4.30M | 17.46M | 45.00M | -- | -- |
| Total Current Liabilities | 21.72M | 34.84M | 110.69M | 45.25M | 36.05M |
|
|
|||||
| Total Current Liabilities | 21.72M | 34.84M | 110.69M | 45.25M | 36.05M |
| Long-Term Debt | 56.51M | 56.11M | 58.64M | 100.30M | 99.90M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 6.80M | 4.40M | 4.52M | 4.60M | 4.68M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 740.00K | 800.00K | 783.00K | 2.32M | 1.99M |
| Total Liabilities | 85.77M | 96.14M | 174.64M | 152.47M | 142.61M |
|
|
|||||
| Common Stock & APIC | 2.13B | 2.12B | 2.12B | 2.12B | 2.12B |
| Retained Earnings | -2.00B | -1.99B | -1.99B | -1.97B | -1.93B |
| Treasury Stock & Other | -5.16M | -5.20M | -5.16M | -4.50M | -4.27M |
| Total Common Equity | 120.16M | 129.44M | 123.03M | 145.95M | 178.51M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 120.16M | 129.44M | 123.03M | 145.95M | 178.51M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 120.16M | 129.44M | 123.03M | 145.95M | 178.51M |
|
|
|||||